Literature DB >> 35603508

Time-course full profiling of circulating miRNAs in neurologically deceased organ donors: a proof of concept study to understand the onset of the cytokine storm.

Andrée-Anne Clément1, Daphnée Lamarche2, Marie-Hélène Masse3, Cécilia Légaré1, Lee-Hwa Tai3,4, Laurence Fleury Deland4,5, Marie-Claude Battista5, Luigi Bouchard1,3,6, Frédérick D'Aragon2,3.   

Abstract

Neurologically deceased organ donors (NDDs) generally display an immune response involving an intense production of pro-inflammatory cytokines referred to as the cytokine storm. The sudden surge of inflammatory mediators in circulation promotes tissue and organ damages and ultimately leads to poor transplant outcome. As microRNAs (miRNAs) are frequently proposed as key regulators of inflammation and are relatively stable in circulation, changes in their profiles could play a role in the onset of the cytokine storm in NDDs. In this proof-of-concept study, we sought to investigate differentially abundant circulating miRNAs in a temporal manner between neurological death and organ recovery and to assess the association between specific miRNAs and levels of inflammatory cytokines in blood. Plasma samples from five NDDs were obtained at multiple time points between organ donation consent and organ recovery. Using a time-course analysis and miRNA sequencing, we identified 32 plasma miRNAs fluctuating between consent and organ recovery (false discovery rate; q-value < 0.1). Eleven miRNAs relatively abundant (>100 reads) and detected in all samples were selected for further biological pathway analysis (miR-486-3p, miR-103a-3p, miR-106b-3p, miR-182-5p, miR-101-3p, miR-10a-5p, miR-125a-5p, miR-146b-5p, miR-26a-5p, miR-423-5p, miR-92b-3p). These miRNAs targeted genes such as c-JUN (TNF signalling pathway) and eEF2 (AMPK pathway), suggesting a potential role in regulation of inflammation. Our results contribute to a better understanding of the miRNAs dynamic after neurological death in organ donors and could potentially be used to predict the related early cytokine storm.Trial registration: ClinicalTrials.gov ID NCT03786991. Registered December 2018.

Entities:  

Keywords:  Organ donation; circulating miRNAs; microRNAs; microtranscriptome; next-generation sequencing; transplantation

Mesh:

Substances:

Year:  2022        PMID: 35603508      PMCID: PMC9586643          DOI: 10.1080/15592294.2022.2076048

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.861


  79 in total

Review 1.  Review of randomized clinical trials of donor management and organ preservation in deceased donors: opportunities and issues.

Authors:  George S Dikdan; Cesar Mora-Esteves; Baburao Koneru
Journal:  Transplantation       Date:  2012-09-15       Impact factor: 4.939

Review 2.  Nuclear microRNAs and their unconventional role in regulating non-coding RNAs.

Authors:  Hongwei Liang; Junfeng Zhang; Ke Zen; Chen-Yu Zhang; Xi Chen
Journal:  Protein Cell       Date:  2013-04-13       Impact factor: 14.870

Review 3.  Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease.

Authors:  Marcelo A Mori; Raissa G Ludwig; Ruben Garcia-Martin; Bruna B Brandão; C Ronald Kahn
Journal:  Cell Metab       Date:  2019-08-22       Impact factor: 27.287

4.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

Authors:  R A Wolfe; V B Ashby; E L Milford; A O Ojo; R E Ettenger; L Y Agodoa; P J Held; F K Port
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

5.  Management of the neurologically deceased organ donor: A Canadian clinical practice guideline.

Authors:  Ian M Ball; Laura Hornby; Bram Rochwerg; Matthew J Weiss; Clay Gillrie; Michaël Chassé; Frederick D'Aragon; Maureen O Meade; Karim Soliman; Aadil Ali; Samantha Arora; John Basmaji; J Gordon Boyd; Bernard Cantin; Prosanto Chaudhury; Marcelo Cypel; Darren Freed; Anne Julie Frenette; Pam Hruska; Constantine J Karvellas; Sean Keenan; Andreas Kramer; Demetrios James Kutsogiannis; Dale Lien; Patrick Luke; Meagan Mahoney; Jeffrey M Singh; Lindsay C Wilson; Alissa Wright; Jeffrey Zaltzman; Sam D Shemie
Journal:  CMAJ       Date:  2020-04-06       Impact factor: 8.262

Review 6.  Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain.

Authors:  Gennadij Raivich; Axel Behrens
Journal:  Prog Neurobiol       Date:  2006-05-22       Impact factor: 11.685

7.  The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy.

Authors:  Rajamiyer V Venkateswaran; Vamsidhar Dronavalli; Peter A Lambert; Richard P Steeds; Ian C Wilson; Richard D Thompson; Jorge G Mascaro; Robert S Bonser
Journal:  Transplantation       Date:  2009-08-27       Impact factor: 4.939

8.  Impact of cytokine expression in the pre-implanted donor lung on the development of chronic lung allograft dysfunction subtypes.

Authors:  T Saito; H Takahashi; H Kaneda; M Binnie; S Azad; M Sato; T K Waddell; M Cypel; M Liu; S Keshavjee
Journal:  Am J Transplant       Date:  2013-10-24       Impact factor: 8.086

9.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support.

Authors:  Ioannis S Vlachos; Konstantinos Zagganas; Maria D Paraskevopoulou; Georgios Georgakilas; Dimitra Karagkouni; Thanasis Vergoulis; Theodore Dalamagas; Artemis G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2015-05-14       Impact factor: 16.971

Review 10.  The Non-Canonical Aspects of MicroRNAs: Many Roads to Gene Regulation.

Authors:  Christiaan J Stavast; Stefan J Erkeland
Journal:  Cells       Date:  2019-11-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.